Website and social media enquiries

For all website and social media enquiries

Suzanne Bailey (Monday - Thursday)
T: 01923 779555
E: [email protected]

Gemma Marks (Friday)
T: 01923 779555
E: gemma @cureparkinsons.org.uk

Latest

Prudential RideLondon-Surrey 46 2020

Make the most of the great outdoors by riding in the 2020 Prudential RideLondon-Surrey 46 in aid of The Cure Parkinson's Trust! This sportive offers a great introduction to cycling on traffic-free roads for those new to cycling and for younger participants...
Elizabeth Day Runs New York Marathon for CPT

Last year The Cure Parkinson’s Trust’s supporter Elizabeth Day took on the magnificent New York Marathon on 3 November to raise funds for our pioneering Parkinson’s research.
'Barnesy's' Biography for Parkinson’s

The Cure Parkinson's Trust would like to say a huge thank you to the inspirational Robert Barnes who has taken the time to write his first book ‘An Englishman Recalls: Memoirs of Robert Barnes’ to raise money for The Cure Parkinson's Trust.
In Memoriam: Sir David Jones - Former Co-founder of The Cure Parkinson's Trust

Sir David Jones, former co-founder of The Cure Parkinson's Trust, died at the end of 2019.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut...
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed Drugs

Our international Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
Alpha-synuclein and Parkinson's

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more

Our Annual Review 2019

Our Annual Review 2019 - your online publication here... Read more